Skip to content
10-Q/A

Quarterly Report

PEGASUS MEDICAL HOLDINGS, INC.

0001140361-21-029535

← back to feed
Filed
Aug 27, 2021 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Aug 26, 2021 1M sh
Operating Cash Flow Q2 2021 · Jun 30, 2021 −$22.21K
Operating Cash Flow Q2 2021 · Jun 30, 2020 $15.11K
Cash And Equivalents Q2 2021 · Jun 30, 2021 $21.31K
Cash And Equivalents Q2 2021 · Dec 31, 2020 $43.51K
Cash And Equivalents Q2 2021 · Jun 30, 2020 $44.23K
Cash And Equivalents Q2 2021 · Dec 31, 2019 $29.12K
Stockholders Equity Q2 2021 · Jun 30, 2021 $12.89K
Stockholders Equity Q2 2021 · Dec 31, 2020 $8.34K
Stockholders Equity Q2 2021 · Jun 30, 2020 $10.12K
Stockholders Equity Q2 2021 · Dec 31, 2019 $10.89K
Current Liabilities Q2 2021 · Jun 30, 2021 $8.42K
Current Liabilities Q2 2021 · Dec 31, 2020 $35.17K
Current Assets Q2 2021 · Jun 30, 2021 $21.31K
Current Assets Q2 2021 · Dec 31, 2020 $43.51K
Total Assets Q2 2021 · Jun 30, 2021 $21.31K
Total Assets Q2 2021 · Dec 31, 2020 $43.51K
Net Income Q2 2021 · Jun 30, 2021 −$11.1K
Net Income Q2 2021 · Jun 30, 2021 −$30.46K
Net Income Q2 2021 · Jun 30, 2020 −$385
Net Income Q2 2021 · Jun 30, 2020 −$770